Clinical Trial Update: An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects [Phase 2, Phase 3]

View source ↗

Summary

This is an open-label Phase 2/3 clinical trial update evaluating the effects of Moxaverine on ocular blood flow in patients with age-related macular degeneratio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Glaucoma

Drugs mentioned

• Moxaverine (moxaverine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Macular Degeneration, Glaucoma | Phase 2, Phase 3 | Status: COMPLETED